ASPIVIX is a Swiss-based medical device company dedicated to R&D, Manufacturing and Sales of technologies for women’s health.
Our vision is to empower women around the world by driving healthcare innovation in areas that are needed the most, thus making a positive impact in women’s everyday life.
Our flagship product, is a next generation, patent protected vacuum-based cervical device that delivers the same manoeuvrability as the traumatic tenaculum - used 80 million times/year - without the reported patient trauma related to pain, bleeding, tissue tear. We believe that women deserve gentler and more modern methods for procedures in gynecology.
Results from “First in Women” Trial in Switzerland are expected in 2H2020.
Should you have any interest or any need for additional information, please feel free to contact us.
Our vision is to empower women around the world by driving healthcare innovation in areas that are needed the most, thus making a positive impact in women’s everyday life.
Our flagship product, is a next generation, patent protected vacuum-based cervical device that delivers the same manoeuvrability as the traumatic tenaculum - used 80 million times/year - without the reported patient trauma related to pain, bleeding, tissue tear. We believe that women deserve gentler and more modern methods for procedures in gynecology.
Results from “First in Women” Trial in Switzerland are expected in 2H2020.
Should you have any interest or any need for additional information, please feel free to contact us.
Location: Switzerland, Vaud, Renens
Employees: 11-50
Total raised: $12M
Founded date: 2015
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors |
| 23.11.2022 | Grant | $5M | - |
| 17.11.2022 | Series A | $5M | - |
| 20.08.2018 | Series A | $2M | - |
Mentions in press and media 43
| Date | Title | Description |
| 11.11.2024 | Strong startup delegation at Medica 2024 | With over 6,100 international exhibitors and a total of 83,000 trade visitors, Medica is the world's leading trade fair for the medical technology industry. Slated to take place from 11-14 November in Düsseldorf, the trade fair brings toge... |
| 01.11.2024 | Swiss ingenuity shines on TIME's Best Inventions 2024 list | TIME has included five Swiss innovations on its latest list of 200 best inventions. Notably, four of these originate from young companies. They are active in a diverse range of sectors, including medtech, cleantech and sport, reflecting th... |
| 15.10.2024 | Navigating New Waters: Leadership Changes in Startups Fueling Innovation | In the fast-paced world of startups, leadership transitions are like the changing tides. They can either propel a company forward or leave it adrift. Recently, several startups have made strategic appointments, bringing seasoned veterans on... |
| 11.10.2024 | Boardroom powerhouses of industry veterans propel startups toward growth | With its NUSHU smart shoes, Magnes has developed a disruptive real-life-monitoring solution to analyze the walking patterns of patients with neurological disorders such as like Parkinson’s disease. The startup has now appointed Evert Dijks... |
| 25.09.2024 | Innosuisse funds 33 projects as part of the Swiss Accelerator | Innosuisse has carried out this call for projects due to Switzerland's non-association to Horizon Europe. Swiss SMEs and start-ups were able to apply for direct financial support for innovation projects with significant innovation potentia... |
| 24.09.2024 | Tia joins Aspivix global ambassador program | In a milestone partnership aimed at improving women's health, ASPIVIX, a leading innovator in gynecological and fertility solutions, and Tia women's health clinics, the modern medical home for women, are redefining the way women experience... |
| 06.09.2024 | Navigating Change: The Evolution of Leadership in Startups | The startup landscape is a dynamic ecosystem. It thrives on innovation, agility, and leadership. Recent shifts in executive roles across various companies highlight this evolution. New leaders bring fresh perspectives, driving growth and ad... |
| 02.09.2024 | Swiss health care startups explore the UK market | Following this achievement, Aspivix has obtained approval from the Medicines & Healthcare products Regulatory Agency (MHRA) for use in the United Kingdom. A non-invassive solution, Carevix, offers a more comfortable and empowering expe... |
| 12.07.2024 | Industry experts avail resources to young companies | From the Top 10 selected startups for the Swiss Prime Site Accelerator Program, VAULTED AG, viboo and Resilientsy emerged as finalists, winning a ticked for an intensive Acceleration Programme. They would collaborate with Swiss Prime Site ... |
| 27.06.2024 | FIT Funding for Aspivix and Xemperia | Aspivix and its non-traumatic device for gynaecological procedures For decades, gynaecological procedures involving access to the uterus have used the same device: Pozzi's forceps, or tenaculum, especially necessary for inserting an IUD. Pr... |
Show more